1.
Marcellusi A, Bini C, Rotundo MA, Arcangeli E, Martinez L, Sorio Vilela F, Mennini FS. Cost-utility analysis of evolocumab in patients with ASCVD in Italy. Grhta [Internet]. 2021 Nov. 2 [cited 2024 Dec. 12];8(1):155-67. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/2255